Difference between revisions of "Involucrin (TG5)"
| Line 29: | Line 29: | ||
|- | |- | ||
| Substrate sequence | | Substrate sequence | ||
| − | | | + | | YLE''Q''QEGQLK |
| + | PKNLE''Q''EE''K''QLELP | ||
| − | + | VKHLE''K''QEA''Q''LELPE | |
| − | + | LELPE''QQ''VGQPK | |
| − | + | LEQQE''K''HLEHP | |
| − | |||
| − | |||
|- | |- | ||
| Structure | | Structure | ||
Revision as of 09:34, 24 July 2007
| Template:Infobox header| Involucrin (TG5) | |
|---|---|
| Involucrin (TG5) | |
| Substrate peptide name | Involucrin (TG5) |
| Synonyms | - |
| Determination type | In situ |
| Source | Homo sapiens |
| Subcellular localization | Cornified envelope |
| Swissprot ID | P07476 |
| Reactive glutamines | Q465, Q489, Q496, Q288 |
| Reactive lysines | K468, K485, K508 |
| Substrate sequence | YLEQQEGQLK
PKNLEQEEKQLELP VKHLEKQEAQLELPE LELPEQQVGQPK LEQQEKHLEHP |
| Structure | No available crystal structure |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:8999895 |
| Notes | |
| Template:Infobox header | | |
.png){kind=link}